KOREA WHO
-
-
-
CEO of Hugel
Chang Daniel Doo-hyun
Right Leader to Drive Future Value, Clear Market Uncertainty
-
Last Updated on Dec 11, 2025
-
CEO of Hugel
Life Summary
Jang Doo-hyun (Daniel Chang) is the Chief Executive Officer of Hugel.
He was born on July 4, 1976.
In 1999, he majored in economics and political science at the University of Michigan in the United States.
After handling finance-related work at AT&T, he moved to CJ Group’s Corporate Strategy Office, where he worked across CJ, CJ Logistics’ U.S. subsidiary and overseas business management, and served as head of CJ CGV’s Vietnam business.
After joining Boryung Holdings as head of the Strategy Planning Office, he served as Executive Vice President in charge of overall operations at Boryung Pharmaceutical, and was appointed CEO of Boryung in August 2021.
In September 2025, he was brought into Hugel as Chief Executive Officer.
He is regarded as the right person to enhance Hugel’s future value and accelerate its global growth.
To reduce market uncertainty, including rumors of Hugel’s sale and concerns over investor exits, there is a need for him to focus on presenting clear management plans and strengthening communication both inside and outside the company.
#Hugel #DanielChang #JangDooHyun #biopharmaceutical #globalgrowth #CEO #corporatestrategy #Boryung #CJGroup #executiveprofile
He was born on July 4, 1976.
In 1999, he majored in economics and political science at the University of Michigan in the United States.
After handling finance-related work at AT&T, he moved to CJ Group’s Corporate Strategy Office, where he worked across CJ, CJ Logistics’ U.S. subsidiary and overseas business management, and served as head of CJ CGV’s Vietnam business.
After joining Boryung Holdings as head of the Strategy Planning Office, he served as Executive Vice President in charge of overall operations at Boryung Pharmaceutical, and was appointed CEO of Boryung in August 2021.
In September 2025, he was brought into Hugel as Chief Executive Officer.
He is regarded as the right person to enhance Hugel’s future value and accelerate its global growth.
To reduce market uncertainty, including rumors of Hugel’s sale and concerns over investor exits, there is a need for him to focus on presenting clear management plans and strengthening communication both inside and outside the company.
#Hugel #DanielChang #JangDooHyun #biopharmaceutical #globalgrowth #CEO #corporatestrategy #Boryung #CJGroup #executiveprofile